11 December 2015 - PHARMAC is pleased to announce the approval of an agreement with Baxter Healthcare Limited to fund Asacol (mesalazine) 800 mg tablets.

For more details, go to: http://www.pharmac.health.nz/news/notification-2015-12-11-asacol/